Back to User profile » Dr Wei Yu
Papers published by Dr Wei Yu:
Characteristics of Immunocytes and Cytokines in Patients with Bloodstream Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae in China
Guo W, Lian X, Li H, Jiang L, Chen Y, Shen P, Yu W
Infection and Drug Resistance 2024, 17:719-725
Published Date: 22 February 2024
A Novel Nomogram for Predicting Risk Factors and Outcomes in Bloodstream Infections Caused by Klebsiella pneumoniae
Chen Y, Ying S, Jiang L, Dong S, Dai J, Jin X, Yu W, Qiu Y
Infection and Drug Resistance 2022, 15:1317-1328
Published Date: 29 March 2022
Genomic and Phenotypic Characteristics for Vibrio vulnificus Infections
Zhang J, Huang Y, Xu H, Ying S, Pan H, Yu W
Infection and Drug Resistance 2021, 14:3721-3726
Published Date: 14 September 2021
In vitro Antimicrobial Activity of Fosfomycin, Rifampin, Vancomycin, Daptomycin Alone and in Combination Against Vancomycin-Resistant Enterococci
Tong J, Jiang Y, Xu H, Jin X, Zhang L, Ying S, Yu W, Qiu Y
Drug Design, Development and Therapy 2021, 15:3049-3055
Published Date: 12 July 2021
Evaluation of Ceftazidime/Avibactam Administration in Enterobacteriaceae and Pseudomonas aeruginosa Bloodstream Infections by Monte Carlo Simulation
Dai Y, Chang W, Zhou X, Yu W, Huang C, Chen Y, Ma X, Lu H, Ji R, Ying C, Wang P, Liu Z, Yuan Q, Xiao Y
Drug Design, Development and Therapy 2021, 15:2899-2905
Published Date: 6 July 2021
Epidemiological characteristics and genetic structure of linezolid-resistant Enterococcus faecalis
Chen M, Pan H, Lou Y, Wu Z, Zhang J, Huang Y, Yu W, Qiu Y
Infection and Drug Resistance 2018, 11:2397-2409
Published Date: 20 November 2018
Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem resistant Acinetobacter baumannii bloodstream infections: cefoperazone–sulbactam associated with resistance and tigecycline increased the mortality
Niu T, Xiao TT, Guo L, Yu W, Chen Y, Zheng B, Huang C, Yu X, Xiao Y
Infection and Drug Resistance 2018, 11:2021-2030
Published Date: 26 October 2018
In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae
Yu W, Luo Q, Shi Q, Huang C, Yu X, Niu T, Zhou K, Zhang J, Xiao Y
Infection and Drug Resistance 2018, 11:577-585
Published Date: 24 April 2018
A retrospective, comparative analysis of risk factors and outcomes in carbapenem-susceptible and carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infections: tigecycline significantly increases the mortality
Xiao T, Yu W, Niu T, Huang C, Xiao Y
Infection and Drug Resistance 2018, 11:595-606
Published Date: 24 April 2018
Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation
Yu W, Ji J, Xiao T, Ying C, Fang J, Shen P, Xiao Y
Drug Design, Development and Therapy 2017, 11:1951-1956
Published Date: 28 June 2017